Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mian Xi

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
The Oncologist|December 28, 2019
Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II StudyBaoqing Chen, Qiwen Li, Qiaoqiao Li, et al.
The Oncologist|April 16, 2023
Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and ChemoradiotherapyXingyuan Cheng, Baoqing Chen, Sifen Wang, et al.
Journal of Radiation Research|July 31, 2012
Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinomaLi Zhang, Mian Xi, Xiao-Wu Deng, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 15, 2021
Modeling the risk of radiation pneumonitis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapyKaiqi Lan, Cheng Xu, Shiliang Liu, et al.
Cancer Research and Treatment|September 8, 2020
Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological BiomarkersYingjia Wu, Jinbin Chen, Lei Zhao, et al.
Cancer Medicine|June 19, 2023
Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinomaHui Jiang, Qiaoqiao Li, Baoqing Chen, et al.
Plos One|December 25, 2013
Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinomaMian Xi, Shi-Liang Liu, Lei Zhao, et al.
Cancers|February 6, 2019
Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant ChemoradiotherapySha Zhou, Lei Zhao, Zhaohui Liang, et al.
The Oncologist|April 3, 2023
Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular CarcinomaYuting Wang, Qiaoqiao Li, Li Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 2020
Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapyKaiqi Lan, Jinhan Zhu, Jun Zhang, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
The Oncologist|December 28, 2019
Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II StudyBaoqing Chen, Qiwen Li, Qiaoqiao Li, et al.
The Oncologist|April 16, 2023
Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and ChemoradiotherapyXingyuan Cheng, Baoqing Chen, Sifen Wang, et al.
Journal of Radiation Research|July 31, 2012
Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinomaLi Zhang, Mian Xi, Xiao-Wu Deng, et al.
Esophagus : Official Journal of the Japan Esophageal Society|June 15, 2021
Modeling the risk of radiation pneumonitis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapyKaiqi Lan, Cheng Xu, Shiliang Liu, et al.
Cancer Research and Treatment|September 8, 2020
Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological BiomarkersYingjia Wu, Jinbin Chen, Lei Zhao, et al.
Cancer Medicine|June 19, 2023
Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinomaHui Jiang, Qiaoqiao Li, Baoqing Chen, et al.
Plos One|December 25, 2013
Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinomaMian Xi, Shi-Liang Liu, Lei Zhao, et al.
Cancers|February 6, 2019
Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant ChemoradiotherapySha Zhou, Lei Zhao, Zhaohui Liang, et al.
The Oncologist|April 3, 2023
Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular CarcinomaYuting Wang, Qiaoqiao Li, Li Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 2020
Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapyKaiqi Lan, Jinhan Zhu, Jun Zhang, et al.
Pageof 11